SubtleMR

SubtleMR is an image processing software that employs convolutional neural network algorithms to enhance MR images by reducing noise across a wide range of anatomical regions or increasing sharpness in head MRIs. The device aims to improve image quality for radiological assessment, with its efficacy demonstrated through performance tests showing quantitative SNR improvements and qualitative enhancements in image clarity and structural definition.

SubtleMR Version 2.0.0 is a Software as a Medical Device (SaMD) that utilizes a convolutional neural network-based algorithm to enhance the quality of Magnetic Resonance (MR) images. The software processes standard DICOM MR images acquired from 1.2 Tesla, 1.5 Tesla, or 3 Tesla scanners, offering functionalities for either image noise reduction or image sharpness enhancement. It operates as a fixed nonlinear filter without a direct user interface, with the choice of enhancement mode determined by the end-user (radiologists in imaging centers, clinics, or hospitals) via DICOM Series Description, command line, or environment variables. The output consists of enhanced images intended to improve diagnostic utility. The device's indications for use have been expanded to include noise reduction for additional anatomical regions: head, spine, neck, abdomen, pelvis, prostate, breast, and musculoskeletal MRI. Furthermore, its capability to increase image sharpness now applies to both contrast-enhanced and non-contrast-enhanced head MRIs. Performance testing, utilizing retrospective clinical data, demonstrated that SubtleMR met its acceptance criteria. For noise reduction, the signal-to-noise ratio (SNR) in selected regions of interest improved on average by ≥5%, while the visibility of small structures was maintained (average change ≤0.5 Likert scale points). For sharpness enhancement, the thickness of anatomic structures and the sharpness of structure boundaries were improved in at least 90% of the test datasets.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What are the specific quantitative differences in signal-to-noise ratio improvement and sharpness enhancement when SubtleMR is applied to images from 1.2T, 1.5T, and 3T scanners respectively?; How does the performance of SubtleMR's noise reduction vary across the newly added anatomical locations (abdomen, pelvis, prostate, breast, musculoskeletal MRI) in terms of SNR improvement and preservation of diagnostic details?; Are there specific MRI sequences (e.g., T1-weighted, T2-weighted, FLAIR, DWI) where SubtleMR demonstrates superior or limited efficacy for noise reduction or sharpness enhancement?; What is the typical processing time for SubtleMR per series or study, and how might this integrate into high-volume clinical workflows?; Beyond the ≥5% average SNR improvement, what was the range and standard deviation of SNR improvement and the Likert scale change for visibility of small structures in the noise reduction performance tests?